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Abstract
Most patients with ischaemic stroke are managed on the ward or in specialty stroke units, but a significant number
requires higher-acuity care and, consequently, admission to the intensive care unit. Mechanical ventilation is
frequently performed in these patients due to swallowing dysfunction and airway or respiratory system
compromise. Experimental studies have focused on stroke-induced immunosuppression and brain-lung crosstalk,
leading to increased pulmonary damage and inflammation, as well as reduced alveolar macrophage phagocytic
capability, which may increase the risk of infection. Pulmonary complications, such as respiratory failure, pneumonia,
pleural effusions, acute respiratory distress syndrome, lung oedema, and pulmonary embolism from venous
thromboembolism, are common and found to be among the major causes of death in this group of patients.
Furthermore, over the past two decades, tracheostomy use has increased among stroke patients, who can have
unique indications for this procedure—depending on the location and type of stroke—when compared to the
general population. However, the optimal mechanical ventilator strategy remains unclear in this population.
Although a high tidal volume (VT) strategy has been used for many years, the latest evidence suggests that a
protective ventilatory strategy (VT = 6–8 mL/kg predicted body weight, positive end-expiratory pressure and rescue
recruitment manoeuvres) may also have a role in brain-damaged patients, including those with stroke. The aim of
this narrative review is to explore the pathophysiology of brain-lung interactions after acute ischaemic stroke and
the management of mechanical ventilation in these patients.
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Background
Acute ischaemic stroke (AIS) is one of the major causes
of morbidity and mortality worldwide [1] and one of the
leading causes for admission to neurological intensive
care units (NICUs) [2]. Over the last decades, the inci-
dence of stroke has been increasing, and despite an over-
all decrease in mortality, it is still the leading cause of
severe disability in the adult population [1]. Approxi-
mately 80% of all strokes are ischaemic; other major
types include intracerebral (ICH) and intraventricular
(IVH) haemorrhage, cerebral venous and sinus throm-
bosis, and subarachnoid haemorrhage (SAH) secondary
to aneurysm leak or rupture [3]. The location of the
stroke is probably the most relevant factor related to the
need for mechanical ventilation (MV), rather than the
particular type of cerebrovascular pathology. In this con-
text, impairment of the brain areas that regulate the level
of consciousness (thalami, the limbic system, the reticu-
lar formation in the brainstem), breathing (respiratory
centres in the cortex, pons, and medulla), and swallow-
ing (medulla and brainstem connections) increases the
risk of respiratory failure [4].
Pulmonary complications—such as respiratory failure,
pneumonia, pleural effusion, acute respiratory distress
syndrome (ARDS), pulmonary oedema, and pulmonary
embolism from venous thromboembolism—may occur
in this group of patients and are associated with a high
risk of mortality [5, 6]. In particular, stroke-associated
pneumonia (SAP) is described as an independent risk
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factor for unfavourable outcome and death [7, 8]. Since
the most frequent extra-cerebral complication of neuro-
logical ICU patients is respiratory failure [5], the devel-
opment of new mechanical ventilation strategies may
potentially improve their outcome [4]. So far, few studies
have addressed the best respiratory management of pa-
tients with AIS. The aim of this manuscript is to review
and describe the pathophysiology underlying the devel-
opment of pulmonary complications and respiratory fail-
ure after AIS and the different ventilator strategies in
this population, focusing on the risk related to oxygen
(O2) therapy and the application of protective lung ven-
tilation. For this purpose, we performed a literature
search of four electronic databases (PubMED, Scopus,
ScienceDirect, Web of Science), using the following
terms: “mechanical ventilation” and “stroke”. Titles and
abstracts were retrieved and independently assessed for
eligibility by two authors (CR, GB). Disagreements were
resolved by discussion and consensus agreement and, if
required, input from a third author (DB).
This narrative review focuses on the information spe-
cific to stroke patients that do not have brain trauma or
intracranial pressure issues, including the concern over
the need for tracheostomy as an intervention to prevent
aspiration pneumonia rather than for primarily pulmon-
ary issues. We also aimed to highlight the different
needs of specific subsets of stroke victims that distinct
profiles of neurological impairment—such as decreased
level of consciousness, cranial nerve deficits, and central
swallow concerns—in order to provide a good roadmap
to guide the generalist intensivist.
The pathophysiology of stroke and the risk of
pulmonary complications
Brain-lung crosstalk
The concept of brain-organ crosstalk has been widely in-
vestigated [9, 10]. Severe brain-damaged patients are com-
monly unable to protect their airway and therefore are
often admitted to the NICU for mechanical ventilation.
Prolonged MV is associated with increased risk of devel-
oping ventilator-associated lung injury, ARDS, pneumo-
nia, and neurogenic pulmonary oedema [11]. Moreover,
ARDS has detrimental effects on the brain, acting syner-
gistically with intracranial hypertension to cause hippo-
campal damage. A study on rats revealed that focal
ischaemic stroke alters the respiratory pattern, induces
oedema and inflammation, and decreases the phagocytic
capability of alveolar macrophages [6]. Remarkably, all of
these changes occurred within 24 h after the induction of
cerebral ischaemia, which is in agreement with the rapid
onset of respiratory failure in stroke patients [12].
The mechanism of lung damage after brain injury is de-
scribed through a “double-hit model”: the catecholamine
storm and the systemic production of inflammatory
mediators (first hit) create a systemic inflammatory environ-
ment which increases pulmonary vascular hydrostatic pres-
sure and activates biological mechanisms that make the lung
more susceptible to mechanical and non-mechanical insults
(second hit), including mechanical ventilation [13]. On the
other hand, lung injury can damage the brain through a
complex interaction between the autonomic, neuro-
inflammatory, neuroendocrine, and immunologic pathways
[14]. Fries et al. [15] compared pigs with hypoxaemia in-
duced by a lavage model of acute lung injury versus pigs with
the same degree of hypoxaemia induced by a reduction in
the fraction of inspired oxygen (FiO2). Brain damage was
greater in the first group, suggesting that acute lung injury
per se leads to neuro-pathologic changes regardless of the
occurrence of hypoxaemia. The lungs can communicate with
the brain through the autonomic and sympathetic nervous
system, leading to a neuro-inflammatory process which trig-
gers the activation of the cytokine and complement cascades
[16], thus contributing to the development of brain oedema
and apoptotic cell death.
Immunological response after stroke
AIS produces profound local and systemic immune re-
sponses that engage all major innate and adaptive immune
compartments. After stroke, damage to the blood-brain bar-
rier (BBB) leads to recruitment of resident (astrocytes and
microglia) and peripheral (primarily neutrophils and mono-
cytes) immune cells to the affected area [17]. The result is a
reduction in circulating immune cells and a depression of
peripheral immunity that increases the susceptibility to infec-
tions [8]. A large body of experimental and clinical evidence
supports the hypothesis of a downregulation of systemic cel-
lular immune responses, with a rapid numerical decrease in
peripheral blood lymphocyte subpopulations and functional
deactivation of monocytes [18]. These changes are most
prominent among patients with larger strokes and are more
likely after strokes located in the insular cortex [8]. Experi-
mental and clinical studies in AIS have also reported in-
creased levels of circulating catecholamines and their
correlation with lymphopaenia. However, the mechanisms of
humoral immunosuppression and bacterial infections remain
controversial [10, 19]. In post-stroke mice, the use of β-
adrenergic receptor antagonists reduces bacterial complica-
tions and mortality rates, which may suggest the importance
of the catecholamine pathway and vagal response in the im-
munosuppression process [19] (Figs. 1 and 2).
Stroke-associated pneumonia
Aspiration pneumonia is one of the major causes of respira-
tory failure after stroke and can be related to a decreased
level of consciousness, with impaired swallowing and dys-
phagia [8]. However, the incidence of pneumonia in stroke
patients is higher when compared to other groups of pa-
tients who suffer from dysphagia or compromised level of
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consciousness, thus suggesting that other mechanisms are
involved, such as immune activation and alteration in lung
injury pathogenesis [20]. PREDICT, a prospective observa-
tional multicentre study, confirmed that both dysphagia
and stroke-induced immunodepression syndrome are inde-
pendent risk factors for aspiration pneumonia [20]. The in-
cidence of SAP ranges between 3.9 and 56.6%, with a
higher incidence in the ICU compared to stroke units or
wards [8]. Several studies have developed clinical scores to
predict SAP with the aim of improving risk stratification in
patients with acute stroke [21, 22], but their use in the clin-
ical setting is uncommon. In current practice, biomarkers
such as C-reactive protein, stroke severity, dysphagia, and
the Centres for Disease Control and Prevention criteria
[22] are more frequently used. The most widely recognised
measure when acute stroke patients are admitted is nil by
mouth status until a swallowing assessment can be com-
pleted [8]. Early mobilisation is recommended as it de-
creases the risk of SAP, while the benefit of antibiotic use
in the acute phase remains unproven [23].
Stroke-associated dysphagia
Prediction of extubation success and safe extubation are
important in stroke patients. A prospective observational
study [24] that focused on extubation readiness in stroke
patients showed that patients who failed in swallowing
tests were those who later experienced extubation fail-
ure. The reintubation rate was 24.1%, and the main
Fig. 1 Brain-systemic crosstalk. After stroke, stimulation of the vagus nerve through nicotinic acetylcholine receptor α7 (nAChRα7) induces
microglial activation, causing reduced alveolar macrophage phagocytic capability and reducing circulating levels of interleukin IL-6 and tumour
necrosis factor TNF-α, thus leading to an anti-inflammatory reflex and lung injury. On the other hand, systemic inflammation consequent to
stroke leads to an increased release of inflammatory mediators such as IL-6 and TNF-α, resulting in lung inflammation and alveolar-capillary injury.
Finally, a sympathetic response with increased expression of inflammatory mediators and hypothalamic-pituitary-adrenal axis activation induces
elevated glucocorticoid secretion, which might be associated with secondary infections and poor outcome
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determinant of reintubation (in half of these patients)
was dysphagia, followed by respiratory complications
[24]. Prolonged endotracheal intubation is a major cause
of swallowing dysfunction, and the determination of
extubation readiness is challenging in this population.
The criteria used in the general population for the predic-
tion of extubation failure are based on airway parameters
and lung mechanics, whereas in stroke patients, neuro-
logical status has a prominent role in the development of
dysphagia and is a leading contributor to poor outcome
[25]. The prevalence of post-extubation dysphagia ranges
from 12 to 69% in the general ICU population, reaching
93% in neurological patients [24]. The main causes of
post-extubation dysphagia are cerebrovascular disease due
to damage to the central swallowing network, pharyngo-
laryngeal lesions, neuropathies, and myopathies, as well as
sedation and mucosal damage [24]. Although several tech-
niques have been developed to diagnose dysphagia, only
videofluoroscopy has been considered the goal standard
for swallowing dysfunction. An interventional study using
fiberoptic endoscopy and including general ICU patients
within 48 h from extubation found that post-extubation
Fig. 2 The role of the vagal pathways in the development of lung injury. The healthy brain can control excess cytokine production via an
inflammatory reflex of the vagus nerve (by activation of the afferent vagus through the celiac ganglion). Stimulation of the vagus nerve through
nicotinic acetylcholine receptor α7 (nAChRα7) regulates microglial activation in the brain, protects neuronal cells from oxidative stress, and
improves functional recovery, contributing to immunosuppression. Expression of nAChRα7 on alveolar macrophages and epithelial cells induces a
reduction of inflammation in the lungs, and, by suppressing the production of pro-inflammatory cytokines (IL-6, TNF-α) through
lipopolysaccharides (LPS) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFK-B), impairs host defence during inflammatory
conditions. Altogether, vagal stimulation during stroke blunts macrophage capabilities, with increased risk of infection and lung injury, while
paradoxically inducing a higher anti-inflammatory response and thus decreasing the risk of lung injury. The balance between these two pathways
accounts for the occurrence, or not, of lung injury. Ach, acetylcholine; NA, noradrenaline
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dysphagia could be diagnosed in 50% of patients, and the
overall incidence of aspiration events was 56%, of which
25% were silent [25]. This technique demonstrated its util-
ity in the diagnosis of post-extubation dysphagia in 69.3%
of patients [26]. In summary, current evidence agrees on
the utility and feasibility of bedside fiberoptic endoscopic
swallowing study for assessment of post-extubation dys-
phagia in patients at risk for aspiration and swallowing
dysfunction.
Ventilator settings
Due to the high incidence of respiratory complications
in stroke patients, optimal ventilator management is
mandatory [5]. The main goal of MV should be to main-
tain appropriate oxygen levels and tight control of car-
bon dioxide tension (PaCO2), without inducing
ventilator-associated lung damage.
Oxygen therapy
Hypoxia is common in stroke patients, and an oxygen
saturation (SaO2) below 90% in the first few hours after
hospital admission is associated with a twofold risk of
mortality [27]. Supplemental oxygen could prevent hyp-
oxia and additional neurological deterioration, but it
could also lead to adverse effects; in fact, hyperoxia is in-
dependently associated with mortality in brain-injured
patients, with a higher risk of delayed cerebral ischaemia
and poor outcome [28]. Oxygen may increase the risk of
respiratory tract infections due to contamination, has a
direct effect on vascular tone and blood pressure [29],
and at high concentrations, causes vasoconstriction and
pulmonary toxicity due to the formation of toxic free
radicals. Oxidative stress is also responsible for the acti-
vation of cell signalling pathways, inducing apoptosis
and neuronal cell death [28, 29]. Evidence from well-
designed trials of oxygen supplementation after acute
stroke is conflicting and insufficient to guide clinical
practice (Table 1). A quasi-randomised study of oxygen
supplementation for acute stroke has shown that routine
oxygen therapy in stroke patients does not reduce mor-
bidity and mortality [30]. The Stroke Oxygen Pilot Study
(SO2S), a multicentre randomised controlled trial of oxy-
gen therapy during the first 3 days in patients with acute
stroke, compared continuous low-dose oxygen therapy
with a nasal cannula at 2–3 L/min versus nocturnal low-
dose versus usual care (oxygen only when needed) [31].
The authors observed that routine prophylactic low-dose
oxygen supplementation did not improve outcome at 3
months [32]. In patients with stroke who have a low ar-
terial oxygen level, adjunctive oxygen treatment is war-
ranted, whereas in non-hypoxic patients, preventive
oxygen therapy is not recommended [32] (Table 2). Re-
cent guidelines on the management of traumatic brain
injury recommend to set partial pressure of oxygen
(PaO2) also considering brain partial tension of oxygen
(PbtO2) or jugular venous saturation (SjvO2) values and
to maintain normoxia [33]. For stroke patients, the same
recommendations could be acceptable, but specific studies
are required. In addition, stroke patients are particularly
susceptible to sleep-disordered breathing, with a prevalence
of obstructive sleep apnoea ranging from 30 to 80%. A
meta-analysis of 29 studies showed that sleep-disordered
breathing is present in up to 72% of stroke patients,
whether haemorrhagic or ischaemic, without significant dif-
ferences between stroke subpopulations. Only 7% of pa-
tients suffered from central sleep apnoea, thus suggesting
that young stroke patients are more susceptible to obstruct-
ive sleep apnoea than their age-matched peers who have
not had a stroke [34]. Therefore, the use of polysomnogra-
phy, limited channel devices, and auto-continuous positive
airway pressure should be implemented for the manage-




There are several commonly accepted indications for in-
tubation of neurological patients (Table 3) [45]. In gen-
eral, the decision to intubate is often triggered by
neurological deficits, such as a Glasgow Coma Score
(GCS) < 9, signs of increased intracranial pressure, gen-
eralised (tonic-clonic) seizures, infarct size > 2/3 of the
middle cerebral artery territory, and midline shift on im-
aging [23]. Patients with acute brain injury, including
stroke, may be at risk for difficult intubation, especially
if there is suspicion of associated trauma. Predicting a
difficult airway is crucial for the selection of appropriate
techniques (i.e. awake fiberoptic versus rapid sequence
induction) and tools (video versus direct laryngoscopy)
[46, 47]. In non-emergency settings, awake intubation is
the procedure of choice in case of anticipated difficult
airway or ventilation, except for patients with elevated
intracranial pressure (ICP). In this case, rapid sequence
intubation is preferred, since it limits the elevation of
ICP induced by laryngoscopy [45]. Adequate oxygen-
ation during intubation is essential for patients with
stroke, to prevent secondary injury of the vulnerable
brain and further ICP elevation [45–47]. In critically ill
patients, 3 min of pre-oxygenation with non-invasive
positive pressure ventilation [48] or a heated high-flow
nasal cannula (HHFNC) at 60–70 L/min [49] may be
more effective than pre-oxygenation with a high-flow
(non-rebreather) face mask. However, some evidence
suggests the use of apnoeic oxygenation (with HHFNC
at 60–70 L/min or a nasal cannula at 15 L/min) during
laryngoscopy [45, 49]. Indeed, HHFNC was associated
with less desaturation in more hypoxaemic patients
when compared to positive pressure ventilation [50].
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Since pre-oxygenation with 100% oxygen is easy to per-
form and has no serious adverse effects, its use is recom-
mended during intubation of stroke patients. Once
intubation is achieved, oxygen concentration should be
decreased immediately to the lowest FiO2 that will result
in a SatO2 ≥ 95% [50].
Ventilator settings
Hypoxaemia and hyper/hypocapnia should be avoided to
decrease the risk of secondary brain injury. PaCO2 is a
powerful determinant of cerebral blood flow [33]; how-
ever, not only hypercapnia is dangerous in stroke patients,
but also hyperventilation, because cerebral vasoconstric-
tion can cause brain tissue hypoxia and compromise cere-
bral compliance and blood flow [51]. No consensus is
available regarding the optimal respiratory rate and tidal
volume (VT) to achieve the PaCO2 target, with higher VT
being generally applied in this group of patients [11].
However, after severe brain injury, higher VT is associated
with both an increased risk of acute lung injury and acute
intracranial hypertension [9, 52]. Similarly, higher driving
pressure is associated with a higher risk for ARDS [52].
Moreover, in patients recovered from acute lung injury,
the shorter is the inspiratory rise time, the shorter will be
the inspiratory work of breathing; also, at 15 cmH2O of
pressure support ventilation, the lowest cycling off criteria
reduced respiratory rate and increased VT [53]. In critic-
ally ill patients requiring MV, protective ventilation with a
VT of 6mL/kg, adequate positive end-expiration pressure
(PEEP) levels and limiting plateau pressure to < 30 cmH2O
has shown to reduce absolute mortality by 10% [54]. How-
ever, clinical trials testing ventilation strategies designed
for lung protection frequently excluded brain-injured pa-
tients; therefore, ventilator management has been scarcely
evaluated in neurocritical settings. Indeed, in critically ill
patients with acute brain injury, the use of protective lung
ventilation is controversial and might even be contraindi-
cated, as it can increase ICP due to permissive hypercap-
nia and the use of high airway pressures during
recruitment manoeuvres [55]. In a porcine model of acute
lung injury, major improvement in cerebral oxygenation
was observed in animals ventilated with low VT when
compared with high VT [56]. A multicentre trial with 749
brain-injured patients (36% in the pre-intervention group
and 46% in the intervention group were stroke patients)
[57] suggested that protective ventilation (VT ≤ 7mL/kg of
ideal PBW and PEEP 6–8 cmH2O) can significantly im-
prove the number of ventilator-free days at day 90, as well
as reduce the mortality rate. No specific studies focusing
on optimal ventilator settings in patients with stroke are
available, and only a minority of patients included in the
large trials exploring the role of protective ventilation on
outcome had stroke; we recommend keeping Pplat be-
tween 18 and 25 cmH2O and minimising respiratory rate
to reduce mechanical power. Future studies are needed to
better define the optimal VT in stroke patients requiring
MV.
PEEP
Application of PEEP improves arterial oxygenation.
However, in brain-injured patients, caution is warranted
because PEEP may worsen or trigger intracranial hyper-
tension [51, 58]. Mascia et al. suggested that ICP in-
creases significantly when PEEP is applied, but only in
patients where PEEP induces alveolar hyperinflation with
a consequent increase in PaCO2, whereas ICP remains
constant when PEEP causes alveolar recruitment with
no change in PaCO2 [58]. In an experimental study in
both healthy and stroke pigs, high PEEP levels (up to
25 cmH2O) did not impair ICP, cerebral oxygenation, or
regional cerebral blood flow [59]. Application of high
PEEP (up to 20 cmH20) in patients with haemorrhagic
stroke resulted in a significant decrease in mean arterial
pressure (MAP) and regional cerebral blood flow, but
further analyses showed that changes in regional cere-
bral blood flow depend on MAP changes as a result of
impaired cerebrovascular autoregulation [59]. Georgiadis
et al. showed that PEEP can be safe in patients with
acute stroke, even after increasing PEEP levels up to 12
mmHg, providing that MAP is maintained [60]. In
Table 2 Respiratory management of patients with stroke
according to 2018 AHA/ASA guidelines [23]
Intubation and ventilation are recommended in patients with decreased
consciousness, bulbar dysfunction with inability to protect the airway, or
intracranial hypertension (level I).
Aim for normoxia and normocapnia (NA).
Continuous monitoring of oxygenation is strongly recommended in
patients with AIS in ICU. Supplemental oxygen should be administered
if SpO2 > 94% (level I).
Supplemental oxygen is not recommended in non-hypoxic patients
(level III).
Hyperbaric oxygen is not recommended, except in case of air embolism
(level III).
AIS acute ischemic stroke, ICU intensive care unit, SpO2 oxygen saturation




Hypoxaemia despite supplemental oxygen
Impaired swallowing and gag reflexes
Inability to clear secretions
Seizures or drugs suppressing respiratory drive
Need for intracranial pressure management
Anticipated neurological or cardiopulmonary decline requiring transport
or immediate treatment
GCS Glasgow Coma Scale
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addition, a recent trial in non-ARDS patients demon-
strated the non-inferiority of a low-VT, low-PEEP strat-
egy as compared to high VT [61]. Therefore, PEEP is
considered safe if (1) haemodynamic status and euvolae-
mia are maintained to minimise the effects of PEEP on
cerebral perfusion pressure and (2) the value of PEEP is
lower than ICP, to avoid a decrease in venous outflow
[55], thus resulting in a beneficial effect on brain oxy-
genation [62] while (3) avoiding excessive over-
distention and keeping the lung at rest [63].
Recruitment manoeuvres
Recruitment manoeuvres (RMs) may improve pulmon-
ary gas exchange and respiratory mechanics [64]. How-
ever, they may also cause intracranial hypertension by
impairing jugular venous outflow and impeding cerebral
venous return to the right atrium [64]. In a study by
Bein and colleagues of patients with brain injury (6 of 11
were stroke patients) and acute lung injury, volume RMs
(which included a 30-s progressive increase in peak pres-
sure up to 60 cmH2O and a sustained pressure at the
same level for the next 30 s) led to a deterioration of
cerebral oxygenation and, simultaneously, a reduction of
MAP and an increase in ICP, with critical reduction of
the cerebral perfusion pressure. In 9 brain-injured pa-
tients (of whom 6 were stroke patients), a stepwise RM
with 3-cmH2O intermittent increments and decrements
of PEEP was applied [65], resulting in a positive correl-
ation between PEEP and ICP and a negative correlation
between PEEP and cerebral perfusion pressure (CPP).
These data suggest that the effects of PEEP on blood
pressure and cerebral perfusion pressure vary greatly in
acutely brain-injured patients and that strict MAP and
ICP monitoring is of benefit when PEEP is applied.
Therefore, RMs could be safely performed when indi-
cated in patients with both stroke and lung injury, espe-
cially if setting a PEEP level lower than the ICP and
maintaining an effective MAP [66].
Prone positioning
Similarly to RMs, prone positioning has demonstrated to
be an efficient technique to improve oxygenation but
should be used cautiously in patients with stroke and re-
duced intracranial compliance, as it can increase intra-
thoracic pressure and raise ICP [67]. Only one study
investigating the effects of the prone position on respira-
tory failure provided data on cerebral haemodynamic in
patients with stroke, with contradictory results [68].
Thus, the benefits and risks of prone positioning in pa-
tients with stroke are still unclear. Nekludov et al. found
a significant improvement of pulmonary oxygenation,
but a rise in ICP in a group of 8 patients with a GCS ≤8
(3 of them with stroke) and pulmonary injury [67]. The-
landersson and colleagues investigated 11 neurological
patients (5 of them with stroke) with FiO2 > 0.4 in prone
position for only 3 h, and also found an increase in sys-
temic oxygenation, but unlike the previous study, without
significant changes in ICP or MAP [69]. Altogether, prone
positioning can present challenges in stroke patients be-
cause of the risk of developing intracranial hypertension
and displacement of neuromonitoring tools. However, it
could be taken into consideration in patients with severe,
refractory hypoxaemia and under strict multimodal
neuromonitoring.
Other ventilation strategies
There are insufficient studies to evaluate the role and
safety of high-frequency oscillatory ventilation (HFOV)
in stroke population. Theoretically, the application of
higher mean airway pressures could decrease cerebral
venous drainage, and the PCO2 clearance could be insuf-
ficient; both aspects are unadvisable in severe brain-
injured patients. Very few observational studies have
evaluated the use of HFOV in adults with acute brain in-
jury, with even fewer focusing on stroke [70]. In a sys-
tematic review of the effects of HFOV on cerebral
perfusion pressure and intracranial pressure, the authors
concluded that, for patients with traumatic brain injury
and ARDS, HFOV may improve oxygenation and in-
crease PaCO2. Thus, if HFOV is considered, continuous
monitoring of oxygen saturation, MAP, PaCO2, and ICP
is paramount [70].
In case of life-threatening hypoxia refractory to con-
ventional MV, the use of rescue therapies has been en-
couraged to re-establish adequate levels of oxygenation
while minimising ventilator-associated injury. In selected
cases, extracorporeal lung support techniques have been
considered [71].
In summary, in stroke patients requiring MV, protect-
ive ventilation with close monitoring of neurological and
respiratory variables is essential to ensure lung safety
and avoid secondary brain injury. Furthermore, monitor-
ing of cerebral oxygenation should be used when pos-
sible to allow the clinician to discriminate between
normal and critically impaired tissue oxygenation and
help refine ventilator settings [9, 55]. In future, non-
invasive cerebral monitoring could be implemented to
individualise ventilator settings [72].
Extubation
Neurological patients experienced prolonged ICU stays
and mechanical ventilation, a higher rate of early trache-
ostomy, and higher incidence of ventilator-associated
pneumonia compared to non-neurological patients [5].
Although often necessary and life-saving, MV is time-
dependently associated with various complications and
may increase morbidity and mortality [73]. Therefore,
weaning from mechanical ventilation has been suggested
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to take place as early as is safely possible. Moreover,
there is evidence that neurological patients are especially
prone to extubation failure, with high reintubation rates,
ranging from 20 to 40% [74]. Prediction of successful
extubation is critical, as both delayed and premature extu-
bation increase complication rates need for tracheostomy,
duration of ICU stay, and mortality [75]. Unfortunately,
classic respiratory predictors for successful extubation in
general critical care (such as VT, respiratory rate, negative
inspiratory force, forced vital capacity, rapid shallow
breathing index, and PaO2/FiO2) are unreliable in brain-
injured patients [76]. The level of consciousness at the
moment of extubation could be considered a risk factor
for extubation failure [77], but a recent study [73] showed
controversial results. In a meta-analysis [74] specifically
looking for predictors of extubation failure in neurocritical
care patients, a low GCS (7–9) was identified as a risk fac-
tor, with a nearly fivefold increased risk of reintubation.
Other factors included the ability to follow commands, se-
cretion texture, and presence of a gag reflex. In a small
retrospective study of middle cerebral artery stroke pa-
tients, a composite GCS score of 8 with an eye subscore of
4 was associated with successful extubation [78]. However,
GCS alone cannot be considered a predictive factor for
extubation success, as it has never been validated in intu-
bated patients whose verbal component is impossible to
assess and often arbitrarily scored [79]. More recently,
Godet et al. [73] developed a clinical score to predict extu-
bation failure in the general brain-injured population with
a GCS < 12 before tracheal intubation, intubated for
neurological reasons, and ventilated for more than 48 h; it
includes upper airway functions (e.g. gag reflex, cough,
and deglutition) and neurological status (evaluated
through the visual subscale of the Coma Recovery Scale-
Revised). However, external validation of this score is
required, and no data specific to stroke patients are avail-
able. Recent data have evaluated new physical features in
patients with severe brain injury. In a multicentre study,
age < 40 years, visual pursuit, attempts at swallowing, and
a GCS > 10 were found to be predictors of successful extu-
bation [80]. On the basis of these items, the VISAGE score
was constructed. If three or more items are positive, an
extubation success rate of 90% can be expected. Visual
pursuit and preserved upper airway reflexes [73], younger
age [81], negative fluid balance, and the presence of cough
have been described as favourable signs of extubation suc-
cess by other observational studies. Further studies are
warranted to confirm the findings of the latest studies on
neurological patients in general and stroke in particular.
Tracheostomy
Up to 45% of patients admitted to the ICU for stroke re-
quire tracheostomy (TT) [81] versus 10–15% in the general
ICU population [5]. Recognised advantages of tracheostomy
compared with prolonged oro-tracheal intubation are a re-
duction of pharyngeal and laryngeal lesions, a better oral
hygiene and nursing care, and higher patient comfort [4].
Predictors that may suggest the decision to perform a
tracheostomy in stroke patients have been described in few
studies [82, 83]. Different types of stroke are associated with
the need for tracheostomy, including large hemispheric
stroke, basilar thrombosis, brainstem infarction, and space-
occupying cerebellar stroke [82]. Indeed, the location and
extension of brain damage and its secondary effects (includ-
ing cerebral oedema and secondary ischaemia) may influ-
ence the need for MV support. In particular, the
compromise of the brain regions which regulate breathing
(respiratory centres in the pons, or medulla), level of con-
sciousness (reticular formation, thalami), and swallowing
(medulla and brainstem) may lead to respiratory failure and
need for tracheostomy [82]. There are two main clinical
scenarios in which mechanical ventilation and tracheos-
tomy are usually considered after stroke. The first is in pa-
tients with such an extensive stroke that ICU admission
and MV are required. In these, long-term ventilation and
prolonged insufficient airway protection if extubation fails
or is deemed infeasible are the main indications for trache-
ostomy [82, 83]. The second scenario is in patients with
stroke of only moderate overall severity, but which affects
the swallowing centres of the brain (such as infarcts of the
brainstem or the medulla oblongata), causing dysphagia. In
this case, the decision to perform a tracheostomy can be re-
lated to severe dysphagia posing a risk of aspiration [84].
In a retrospective study by Szeder et al. [85] on patients
with intracranial haemorrhage, features associated with the
need for TT were GCS < 9 at day 3 as well as radiological
findings such as hydrocephalus, midline shift, and intraven-
tricular haemorrhage. Schonenberger et al. [83] proposed the
stroke-related early tracheotomy (SET) score to screen pa-
tients for prolonged intubation and need for TT by combin-
ing neurological parameters (e.g. dysphagia and GCS < 10),
neuroimaging features (e.g. brainstem lesion, hydrocephalus,
intracranial haemorrhage volume > 25mL), general organ
function, and surgical procedures. Furthermore, Steidl et al.
conducted a two-centre, prospective observational study on
both ischaemic and haemorrhagic stroke patients to evaluate
the extubation rate over tracheostomy. Overall, 47% of pa-
tients were tracheostomised without any extubation attempt,
whereas 53% were primarily extubated. Among patients pri-
marily tracheotomised, most had haemorrhagic stroke,
higher National Institute of Health Stroke Scale, and lower
Glasgow Coma scores on admission. Additionally, they re-
ceived more neurosurgical treatments as compared to those
extubated [86]. As can be deduced by the literature, the opti-
mal timing of TT in stroke patients is still unclear. Potential
benefits of early TT (such as ventilation duration and length
of stay, ventilator weaning, airway safety, rate of pneumonia,
outcome, and mortality) have yet to be proven [4]. McCann
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et al. demonstrated a reduced length of stay in patients
undergoing earlier (within 1week) tracheostomy and percu-
taneous endoscopic gastrostomy (PEG) placement in patients
with haemorrhagic stroke [87]. A recent meta-analysis by
McCredie et al. evaluated the effect of early versus late TT
or prolonged endotracheal intubation in acute brain-injured
patients. Ten trials met the selection criteria. Early TT re-
duced long-term mortality and duration of mechanical venti-
lation, but insufficient trials were available to perform
subgroups analysis; thus, the study refers to the general
neuro-ICU population, and no specific data are reported
about stroke patients [88]. Overall, as procedural risk is low
and early tracheostomy does not seem to affect the clinical
course of the ventilated stroke patient, it is suggested that
ventilation needs be assessed after the first week of intensive
care and tracheostomy considered if an extubation attempt
failed or is judged not to be feasible [4].
Recommendations and conclusions
Although there are no specific data regarding the effect
of respiratory management on stroke patients’ outcomes,
specific ventilator strategies in this population could po-
tentially improve neurologic outcome and prevent re-
spiratory failure by correcting modifiable risk factors or
Fig. 3 Recommended mechanical ventilation strategies for patients with acute ischaemic stroke. Abbreviations: PEEP, positive end-expiratory
pressure; O2, oxygen; CO2, carbon dioxide
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controlling brain-induced inflammation of distal organs,
mainly the lungs. Protective ventilation has to be consid-
ered in this population to obtain the target of normoxia
and normocapnia avoiding high VT. Because of the lack
of clear evidence and the poor quality of the studies
available, clinical decisions regarding ventilator strategies
in stroke patients should be made on a case-by-case
basis, considering patients’ characteristics, risks, and
benefits, as well as prognosis and neurological status,
using multimodal brain monitoring to assess cerebral
haemodynamic and oxygenation and to evaluate the ef-
fects of protective ventilation (in particular of PaCO2
and PEEP). We therefore propose a list of recommenda-
tions based on the available literature (Fig. 3). Further
trials are needed to guide ventilation management in
acute ischaemic stroke and to assess possible disparities
between the different aetiologies of stroke.
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